Long term, tamoxifen stops more cancer than Evista
Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co’s Evista, but with a greater risk of some other cancers and blood clots.
Read more on Reuters via Yahoo! News
Product Description
In Europe and the U.S., we have a forty to fifty percent chance of illness from cancer at some time in our life. So what do you do if you are diagnosed with the disease? The harshness of orthodox treatments (surgery, radiation and chemotherapy) are well-known. Their use is widespread, but their results are not very impressive. Faced with these options, informed patients are increasingly seeking alternative and complementary strategies to take control of healing thei… More >>
» Read more: Cancer Recovery Guide: 15 Alternative and Complementary Strategies for Restoring Health
Using gold nanoparticles to hit cancer where it hurts
( Georgia Institute of Technology ) Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk.
Read more on EurekAlert!